Precision Optics SEC Filings

Precision Optics Corporation, Inc. (POCI) reported that one of its directors received a grant of 30,000 stock options on 11/17/2025. The options have an exercise price of $4.33 per share and are exercisable for an equal number of shares of common stock, with an expiration date of 11/17/2035. They were granted under the company’s 2022 Equity Incentive Plan.

The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains in continuous employment with Precision Optics through each vesting date. Following this grant, the director holds 30,000 derivative securities directly.

Precision Optics Corporation, Inc. (POCI) reported an insider equity award for a director. The filing shows a grant of stock options, which are rights to buy common stock in the future at a fixed price.

The director received 30,000 stock options with an exercise price of $4.33 per share, becoming exercisable over time. According to the filing, these options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains in continuous employment with the company through each vesting date. The options were granted under the company’s 2022 Equity Incentive Plan and are scheduled to expire on November 17, 2035.

Precision Optics Corporation, Inc. (POCI) reported an equity award to one of its directors. On 11/17/2025, the director received stock options giving the right to buy 30,000 shares of POCI common stock at an exercise price of $4.33 per share. These options expire on 11/17/2035 and were granted under the company’s 2022 Equity Incentive Plan.

The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains continuously employed by the company through each applicable vesting date.

Precision Optics (POCI) filed its quarterly results for the period ended September 30, 2025. Revenue rose to $6.68 million from $4.20 million a year ago, driven by a near tripling in Systems Manufacturing sales as programs scaled. Despite higher sales, profitability weakened: gross margin fell to 14.2% from 26.6%, and net loss widened to $1.64 million (basic and diluted loss per share $0.21), matching the prior-year per‑share loss on a higher share count.

Engineering Design Services revenue decreased as work transitioned to production, Micro Optics was soft on delayed defense orders, and Ross Optical grew modestly. Operating cash flow was a small positive at $78,227, while cash ended at $1.39 million. Accounts payable and contract liabilities increased alongside activity. The company obtained lender waivers of its debt service coverage covenant for fiscal 2024 and 2025; as of September 30, 2025, it was not in compliance with the 1.20x quarterly test, and future advances under the revolver depend on meeting that covenant. Management states current plans, potential credit availability, and access to capital markets are expected to support at least 12 months of operations.

Precision Optics Corporation (POCI) disclosed a Form 4 showing an inducement stock option grant to its Chief Operating Officer. On October 1, 2025, the executive received options to purchase 60,000 shares of common stock at an exercise price of $4.34 per share.

The option vests in three equal annual installments beginning October 1, 2026, and expires on October 1, 2035. Following the grant, the reporting person beneficially owns 60,000 derivative securities, held directly.

Precision Optics Corporation (POCI)no securities are beneficially owned as of 10/01/2025.

The filing is marked as Form filed by One Reporting Person and was executed by Joseph N. Forkey as attorney-in-fact, with an attached Exhibit 24 – Power of Attorney.

Precision Optics Corporation (POCI) filed Amendment No. 1 to its Annual Report to include Items 10–14 of Part III after determining it would not file a definitive proxy within 120 days of fiscal year-end. The amendment updates directors and executive officers, governance practices, executive and director compensation, beneficial ownership, and auditor fees, and adds new Section 302 officer certifications.

No financial statements are included, and Section 906 certifications are not required for this amendment. Board changes include the appointments of Buell G. Duncan on February 28, 2025 and Joseph P. Pellegrino, Jr. on March 19, 2025, and the resignations of Dr. Richard B. Miles on February 28, 2025 and Peter V. Anania on March 14, 2025. Compensation updates include a bonus of 20,000 shares to the CEO valued at $94,200 at $4.71 per share and option grants (CEO 200,000; CFO 50,000; COO 40,000, subject to forfeiture upon departure on October 31, 2025). Shares outstanding were 7,714,701 as of September 20, 2025. Audit fees totaled $173,746 for the year ended June 30, 2025.

Precision Optics Corporation, Inc. (POCI) filed a Form 10-K reporting fiscal year results and disclosures for the year ended June 30, 2025. The company disaggregates revenue by two segments: Systems Manufacturing with $8,290,225 and MicroOptics Lab with $2,135,562. The consolidated results show a significant operating loss of $5,551,291 and a loss before income taxes of $5,778,310. Stockholders' equity reflects 7,714,701 shares outstanding at June 30, 2025.

Liquidity and financing actions are highlighted: net proceeds from a registered direct offering in August 2024 were approximately $1.2 million and an unregistered placement in February 2025 generated gross proceeds of approximately $5.1 million. Contract liabilities increased to $1,773,735 from $405,278. Long-term debt, net of current maturities, is reported as $1,289,205, and certain debt covenants required an equity raise of at least $4.5 million, which the company satisfied on February 21, 2025.